Conecte-se

Bibliografias temáticas / Leukemia Chemotherapy / Livros

Siga este link para ver outros tipos de publicações sobre o tema: Leukemia Chemotherapy.

Livros sobre o tema "Leukemia Chemotherapy"

Autor: Grafiati

Publicado: 4 de junho de 2021

Última modificação: 28 de janeiro de 2023

Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos

Selecione um tipo de fonte:

Veja os 50 melhores livros para estudos sobre o assunto "Leukemia Chemotherapy".

Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.

Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.

Veja os livros das mais diversas áreas científicas e compile uma bibliografia correta.

1

Ueda, Takanori, ed. Chemotherapy for Leukemia. Singapore: Springer Singapore, 2017. http://dx.doi.org/10.1007/978-981-10-3332-2.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

2

Schmidt, Carolina Witchmichen Penteado, e Kaléu Mormino Otoni, eds. Chemotherapy and Pharmacology for Leukemia in Pregnancy. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-54058-6.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

3

Heinemann, Volker. Supportive therapy in leukemia patients: Clinical handbook with checklist. Stuttgart ; New York: G. Thieme Verlag ; New York : Thieme Medical Publishers, 1993.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

4

Rebirth: A leukemia survivor's journal of healing during chemotherapy, bone marrow transplant and recovery. [Place of publication not identified]: Xlibris Corp., 2009.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

5

1946-, Cheson Bruce D., Keating Michael J. 1943- e Plunkett William 1943-, eds. Nucleoside analogs in cancer therapy. New York: M. Dekker, 1997.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

6

1951-, Pui Ching-Hon, ed. Treatment of acute leukemias: New directions for clinical research. Totowa, N.J: Humana Press, 2003.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

7

Hancock, Sarah. Fludarabine as first line therapy for chronic lymphocytic leukaemia. Birmingham: University of Birmingham, Department of Public Health and Epidemiology, 2003.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

8

Kaspers, G. J. L., 1963-, Pieters R e International Symposium on Drug Resistance in Leukemia and Lymphoma (3rd : 1998 : Amsterdam, Netherlands), eds. Drug resistance in leukemia and lymphoma III. New York: Kluwer Academic/Plenum Press, 1999.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

9

Heim, Marcel U. The leukemia patient as a partner in therapy: A guidebook for patients, relatives, nurses, and physicians. Stuttgart: GTV Stuttgart, 1994.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

10

Kaspers, G. J. L., 1963-, ed. Drug resistance in leukemia and lymphoma: The clinical value of laboratory studies. Chur, Switzerland: Harwood Academic Publishers, 1993.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

11

W, Hiddemann, ed. Acute leukemias: Pharmacokinetics and management of relapsed and refractory disease. Berlin: Springer-Verlag, 1992.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

12

A handbook of essential drugs and regimens in hematological oncology. Chur: Harwood Academic Publishers, 1991.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

13

Sylvie, St-Hilaire, e Bellerive Magalie, eds. L'histoire de Casse-Tête: La pouliche leucémique. Moncton, N.-B: Éditions de la Francophonie, 2006.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

14

Lyman, Gary H. Chemotherapy for Chronic Lymphocytic Leukemia. Oxford University Press, 2012.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

15

Bennett, Lunawati L. Frontiers in Leukemia Pharmacotherapy. Nova Science Publishers, Incorporated, 2019.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

16

Ueda, Takanori. Chemotherapy for Leukemia: Novel Drugs and Treatment. Springer, 2018.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

17

Chemotherapy for Leukemia: Novel Drugs and Treatment. Springer, 2017.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

18

Ueda, Takanori. Chemotherapy for Leukemia: Novel Drugs and Treatment. Springer, 2017.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

19

Bryson, James Scott. Characteristics of reovirus-mediated chemoimmunotherapy of murine L1210 leukemia. 1985.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

20

Farone, Anthony Louis. Interleukin-2 chemoimmunotherapy of murine L1210 leukemia. 1988.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

21

Farone, Anthony Louis. Interleukin-2 chemoimmunotherapy of murine L1210 leukemia. 1988.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

22

Koenigsberg, Adam David. Alpha/Beta and Gamma interferon responses during reovirus-mediated chemoimmunotherapy of L1210 leukemia. 1988.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

23

Heinemann, Volker, e Ulrich Jehn. Supportive Therapy in Leukemia Patients (Supportive Measures in Oncology). Thieme Publishing Group, 1992.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

24

Kaspers, G. J. L., 1963-, Pieters R e Veerman A. J. P, eds. Drug resistance in leukemia and lymphoma II. Amsterdam, the Netherlands: Harwood Academic Publishers, 1997.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

25

Gill, Harinder, Yok Lam Kwong e Farhad Ravandi, eds. Acute Promyelocytic Leukemia - Towards a Chemotherapy-Free Approach to Cure in All Patients. Frontiers Media SA, 2022. http://dx.doi.org/10.3389/978-2-88974-475-6.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

26

Schmidt, Carolina Witchmichen Penteado, e Kaléu Mormino Otoni. Chemotherapy and Pharmacology for Leukemia in Pregnancy: Guidelines and Strategies for Best Practices. Springer International Publishing AG, 2020.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

27

Supportive Measures of Oncology. Thieme-Stratton Corp, 1998.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

28

Farone, Anthony L. Characterization of the immune responses during chemoimmunotherapy of murine L1210 leukemia. 1992.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

29

Roman, Eve, Alexandra Smith e Lorelei Mucci. Leukemias. Oxford University Press, 2018. http://dx.doi.org/10.1093/oso/9780190676827.003.0028.

Texto completo da fonte

Resumo:

Leukemias are a diverse group of acute and chronic haematological malignancies, that account for 2% to 3% of cancers globally. Recent advances in molecular biology and therapy have transformed the landscape for several leukemia subtypes changing some, but by no means all, from rapidly fatal diseases to treatable conditions with a good prognosis. In general, however, this progress has not been matched by new aetiological insights. Albeit accounting for a relatively small proportion, genetic predisposition syndromes such as neurofibromatosis, Li-Fraumeni and Trisomy 21, have the biggest impact in children and young adults. At older ages, established chemical, physical and biological risk factors, which explain only a small proportion of the total disease burden, include chemotherapy for a preceding cancer, ionizing radiation, and the viral infections human T-cell lymphotropic virus type 1 (HTLV-1) which causes the rare adult T-cell leukemia/lymphoma (ATLL) and the human immunodeficiency virus (HIV) which is associated with an increased risk of acute lymphoid leukaemias. Workplace exposures to potential carcinogens such as benzene, butadiene, and styrene have also been linked to increased risk of leukemia.

Estilos ABNT, Harvard, Vancouver, APA, etc.

30

National Institute for Clinical Excellence. Guidance on the use of fludarabine for B-cell chronic lymphocytic leukaemia. London, 2001.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

31

Haas, David Gerard. Cytotoxic T lymphocyte and natural killer cell responses following chemoimmunotherapy of murine L1210 leukemia. 1986.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

32

Acute Myelogenous Leukemia in Childhood: Implications of Therapy Studies for Future Risk-Adapted Treatment Strategies. Springer, 2011.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

33

Ritter, Jörg, Ursula Creutzig e Günther Schellong. Acute Myelogenous Leukemia in Childhood: Implications of Therapy Studies for Future Risk-Adapted Treatment Strategies. Springer London, Limited, 2012.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

34

Creutzig, U., e J. Ritter. Acute Myelogenous Leukemia in Childhood: Implications of Therapy Studies for Future Risk-Adapted Treatment Strategies. Springer, 1990.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

35

1946-, Creutzig U., Ritter Jörg e Schellong Günther, eds. Acute myelogenous leukemia in childhood: Implications of therapy studies for future risk-adapted treatment strategies. Berlin: Springer-Verlag, 1990.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

36

Linet, Martha S., Lindsay M. Morton, Susan S. Devesa e Graça M. Dores. Leukemias. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0038.

Texto completo da fonte

Resumo:

The 2001 World Health Organization (WHO) classification of hematopoietic and lymphoid neoplasms categorized “the leukemias” into two major groupings—myeloid and lymphoid. Myeloid neoplasms, which are the primary focus of this chapter, include acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and myeloproliferative neoplasms (MPN). Lymphoid neoplasms are mostly reviewed as part of non-Hodgkin lymphoma in Chapter 40 of this volume, although descriptive patterns and selected etiologic studies are briefly discussed in this chapter because of historical trends. Worldwide, leukemias are ranked eleventh among all cancer types, comprising approximately 2.5% of all malignancies. Exposure to ionizing radiation and certain chemical carcinogens (e.g., cytotoxic chemotherapy, benzene, formaldehyde) are the most consistently associated risk factors for MDS and/or AML. Radiation has been linked with CML, and cigarette smoking with AML. Fewer risk factors have been identified for MPNs. Some evidence implicates increased risks of AML in rubber workers, farmers, and other agricultural workers.

Estilos ABNT, Harvard, Vancouver, APA, etc.

37

1951-, Pui Ching-Hon, ed. Treatment of acute leukemias: New directions for clinical research. Totowa, N.J: Humana Press, 2003.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

38

Pui, Ching-Hon. Treatment of Acute Leukemias: New Directions for Clinical Research (Current Clinical Oncology). Humana Press, 2003.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

39

Vehling-Kaiser, Ulla, e Marcel U. Heim. The Leukemia Patient As Partner in Therapy: A Guidebook for Patients, Relatives, Nurses and Physicians (Supportive Measures in Oncology/Import). Thieme Medical Pub, 1994.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

40

Fridbinstons, Pit Alex. Causes of Thrombocytopenia: Enlarged Spleen, Anemia, Leukemia, Pregnancy, Heavy Alcohol Consumption, Viral Infections, Chemotherapy Medications, Hemolytic Uremic Syndrome, Thrombotic Thrombocytopenic Purpura. Independently Published, 2021.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

41

Cheson. Nucleoside Analogs Cancer Therapy (Basic and Clinical Oncology, 12). Informa Healthcare, 1997.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

42

KAS, GERT-JAN L. Drug Resistance in Leukemia and Lymphoma: The Clinical Value of Laboratory Studies. Taylor & Francis, 1993.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

43

Plunkett, W., M. Keating, W. Hiddemann, T. Büchner e B. Wörmann. Acute Leukemias: Pharmacokinetics and Management of Relapsed and Refractory Disease. Springer London, Limited, 2012.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

44

Buchner, T., e W. Hiddemann. Acute Leukemias: Pharmacokinetics and Management of Relapsed and Refractory Disease (Haematologie Und Bluttransfusion). Springer-Verlag, 1992.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

45

Acute Leukaemias (Hamatologie und Bluttransfusion). Springer-Verlag Berlin and Heidelberg GmbH & Co. K, 1992.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

46

1926-, Cacciola E., Deisseroth Albert B. 1941- e Giustolisi R, eds. Hemopoietic growth factors, oncogenes, and cytokines in clinical hematology: Current aspects and future directions. Basel: Karger, 1994.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

47

Negative regulators of hematopoiesis: Studies on their nature, action, and potential role in cancer therapy. New York, N.Y: New York Academy of Sciences, 1991.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

48

Najman, Albert, Athanasius Anagnostou e Nicholas Dainiak. Negative regulators of hematopoiesis : Studies on their nature, action, and potential role in cancer therapy. New York Academy of Sciences, 1991.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

49

Athanasius, Anagostou, Dainiak Nicholas, Najman Albert e International Conference on Negative Regulators of Hematopoiesis, (2nd : 1990 : Providence, R.I.), eds. Negative regulators of hematopoiesis: Studies of their nature, action, and potential role in cancer therapy. New York, N.Y: New York Academy of Sciences, 1991.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

50

Anagnostou, Athanasius, e Nicholas Dainiak. Negative Regulators of Hematopoiesis: Studies on Their Nature, Action, and Potential Role in Cancer Therapy (Annals of the New York Academy of Scien). New York Academy of Sciences, 1991.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

Oferecemos descontos em todos os planos premium para autores cujas obras estão incluídas em seleções literárias temáticas. Contate-nos para obter um código promocional único!